Rentschler Biopharma Nukleus Building Laupheim

Our Offering

As a leading CDMO, we transform innovative ideas into life-saving biopharmaceuticals. We master a high level of complexity and achieve the best solutions for our clients around the world by leveraging the framework of our strong alliances. Excellence in consultation, project planning and regulatory support, are part of our DNA as a reliable collaborator. Our full-service portfolio offered out of our headquarters in Laupheim, southern Germany, and a site in Milford, Massachusetts, USA (near Boston), is innovatively complemented by our team specializing in cell and gene therapy in Stevenage, UK.

Discover our services

Rentschler Biopharma has been our main partner for drug substance manufacturing for many years. We rely on them heavily and have not been disappointed so far.

– Consultant, US

Our Commitment

Together with our clients and partners, we are committed to advancing medicine to save lives. Our dedication to patients with serious and rare diseases motivates us to give our best every day. In this way, we make a decisive contribution to the global availability of biopharmaceuticals that provide essential therapies for millions of people.

Our Track Record speaks for itself...

50
160+
Our clients span small biotech companies to big pharma
17
About
60%
About
60%
Expertise with more than
300

Get in Touch with our Communications Team

Dr. Latika Bhonsle-Deeng
Global Head of Communications and Spokesperson

*Required Fields